The observation of increased activation of SMAD3 and the strong modulation of TGF-β target genes in consequence of 5FU treatment in chemoresistant colon carcinoma cells, led us to hypothesize a possible role of the TGF-β molecule in the cell response to 5FU. The gene discussed is TGFB1; the disease is colon carcinoma.